Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

L1CAM signaling through planar cell polarity drives SOX2 expression and lung adenocarcinoma metastasis.

Nature communications·2026
Same author

NSCLC brain metastases exhibit reduced HLA-I antigen presentation machinery and immune evasion independent of IFNγ signaling defects.

Molecular cancer·2026
Same author

Metastasis as a Multiorgan Disease: Toward Organ-Informed Precision Oncology.

Cancer discovery·2026
Same author

CLO26-115: Association Between Geriatric Assessment Variables and Treatment Completion in Older Adults With Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy and Immunotherapy: The MSKCC Experience.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.

Nature·2026
Same author

Tumor Cell Clustering Enhances Metastatic Competence by Regulating the H3K36 Histone Demethylase KDM2A.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 17, 2026

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion
05:23

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion

Published on: July 7, 2023

Tumor self-seeding by circulating cancer cells.

Mi-Young Kim1, Thordur Oskarsson, Swarnali Acharyya

  • 1Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Cell
|January 13, 2010
PubMed
Summary
This summary is machine-generated.

Cancer cells can return to their original tumor, a process called tumor self-seeding. This aggressive circulating tumor cell (CTC) behavior accelerates cancer growth and may explain local recurrence after surgery.

More Related Videos

Lung Tumor Cell Recruitment Assay
04:28

Lung Tumor Cell Recruitment Assay

Published on: February 26, 2019

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections
06:09

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Published on: February 9, 2020

Related Experiment Videos

Last Updated: Jun 17, 2026

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion
05:23

Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion

Published on: July 7, 2023

Lung Tumor Cell Recruitment Assay
04:28

Lung Tumor Cell Recruitment Assay

Published on: February 26, 2019

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections
06:09

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Published on: February 9, 2020

Area of Science:

  • Oncology
  • Cancer Biology
  • Metastasis Research

Background:

  • Metastasis is traditionally viewed as a unidirectional spread of cancer cells from a primary tumor to distant sites.
  • The fate and behavior of circulating tumor cells (CTCs) after dissemination are not fully understood.

Purpose of the Study:

  • To investigate the potential for circulating tumor cells (CTCs) to colonize their tumors of origin.
  • To identify the mechanisms and consequences of this "tumor self-seeding" process in preclinical cancer models.

Main Methods:

  • Utilized mouse models of breast cancer, colon cancer, and melanoma.
  • Analyzed the role of specific cytokines (IL-6, IL-8), enzymes (MMP1/collagenase-1), and cytoskeletal components (fascin-1) in CTC infiltration.
  • Investigated the impact of self-seeding on tumor growth, angiogenesis, and stromal cell recruitment, examining factors like CXCL1.

Main Results:

  • Demonstrated that aggressive CTCs, including those with metastatic tropism for bone, lung, or brain, can colonize their primary tumors (tumor self-seeding).
  • Identified IL-6 and IL-8 as key attractants for CTCs and MMP1/collagenase-1 and fascin-1 as mediators of infiltration into mammary tumors.
  • Showed that self-seeding accelerates tumor growth, angiogenesis, and stromal recruitment, partly via CXCL1.

Conclusions:

  • Circulating tumor cells (CTCs) can colonize their tumors of origin, challenging the unidirectional metastasis model.
  • Tumor self-seeding, mediated by aggressive CTCs and specific molecular factors, can enhance tumor progression.
  • This process may elucidate links between tumor characteristics, prognosis, and local recurrence after seemingly complete resection.